Sails of Hope Charity Banquet
🌟 Celebrating Love, Research, and Hope 🌟
On December 17, 2023, Sails of Hope proudly collaborated with the Ruiou Rare Disease Foundation for the spectacular 2024 New Year Charity Banquet held at the Alila Wuzhen Hotel in Zhejiang, China.
Key Achievements
-
With the support of 105 esteemed guests, the banquet successfully raised an incredible total of ¥985,492. Three companies also generously provided technical donations.
-
The entire proceeds from the banquet will be dedicated to supporting rare disease research initiatives, reinforcing our collective mission to make medical care accessible to everyone.
Guests
Key members of Sails of Hope and six of Ruiou Foundation's co-founders graced the occasion, adding prestige and gravitas to the event
-
Mr Danny J. Tan, Co-Founder of Sails of Hope; Visiting scholar at Zhejiang University School of Medicine
-
Ms Raina Du, Executive Director of Sails of Hope Greater China
-
Mr. Huang Rufang, Secretary-General of Ruiou Foundation and Founder of Cord Rare Disease Center.
-
Dr. Duan Tao, Founder of Shanghai Chuntian Medical Management and Former Director of Shanghai First Maternity and Infant Health Hospital.
-
Mr. Shao Wenbin, Vice President of IQVIA and General Manager of Business Solutions for Greater China.
-
Mr. Yan Zhiyu, Co-founder, Chairman, and CEO of Shufang Pharmaceuticals.
-
Ms. Cao Xiaochun, Co-founder, Executive Director, and President of Tiger Pharmaceuticals.
-
Mr. Pan Oudong, Founder and Chairman of Yuan Biology.
Artistic Contributions:
The event also featured 46 pieces of artwork donated by various contributors, including paintings, calligraphy, ceramics, and handicrafts. These pieces, donated by 29 individuals, symbolize a collective effort to support our cause.
Focus on Rare Disease Research:
All the projects showcased at the banquet focus on rare disease research and translational medicine. These initiatives aim to empower the field of rare disease research. As we step into the new year, Ruiou remains committed to making a lasting contribution to the vision of "medication for every rare disease patient."
